| dc.description.abstract | As the population ages worldwidely and the number of chronically ill patients rises year by year, the Global Diabetes Association estimates that the number of people with diabetes on earth will reach 629 million in 2045, so the demand for blood glucose testing products is increasing. However, due to the health care reform of former President Obama, certain industrial structural problems have appeared in the largest market for the blood glucose detector industry- the United States. In the meanwhile, Chinese manufacturers have joined the market and competed in price-cutting. As a result, the blood glucose detector market has become the red sea. In such an unprofitable situation, four former major factories of the blood sugar have withdrawn from the market. Facing such a circumstance, the main motivations of this study are the effects, due to the change of the market, to their selling strategies, the impact on their financial statements and the future development of vendors in Taiwan.
This research is based on a study to the leading manufacturers of three listed cabinets in Taiwan′s blood glucose detector industry: TaiDoc, Apexbio and Bionime. Based on the analysis of their financial statements together with industry information, it is hoped that one can understand the impact of market changes on individual companies, the company′s response to the change of market, and their future developments through such analyses.
The study found that in the current competing environment of the blood sugar measurer market, the gross profit of the three companies mentioned above showed a downward trend. In order to consolidate the market, the selling strategies must be adjusted and the cost of the product must be reduced. The launch of other products is also imperative.
| en_US |